301 related articles for article (PubMed ID: 30020142)
61. 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease.
Kondoh Y; Makino S; Ogura T; Suda T; Tomioka H; Amano H; Anraku M; Enomoto N; Fujii T; Fujisawa T; Gono T; Harigai M; Ichiyasu H; Inoue Y; Johkoh T; Kameda H; Kataoka K; Katsumata Y; Kawaguchi Y; Kawakami A; Kitamura H; Kitamura N; Koga T; Kurasawa K; Nakamura Y; Nakashima R; Nishioka Y; Nishiyama O; Okamoto M; Sakai F; Sakamoto S; Sato S; Shimizu T; Takayanagi N; Takei R; Takemura T; Takeuchi T; Toyoda Y; Yamada H; Yamakawa H; Yamano Y; Yamasaki Y; Kuwana M;
Respir Investig; 2021 Nov; 59(6):709-740. PubMed ID: 34602377
[TBL] [Abstract][Full Text] [Related]
62. Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study.
Chan C; Ryerson CJ; Dunne JV; Wilcox PG
BMC Pulm Med; 2019 Oct; 19(1):192. PubMed ID: 31672127
[TBL] [Abstract][Full Text] [Related]
63. Rituximab for the treatment of connective tissue disease-associated interstitial lung disease.
Chartrand S; Swigris JJ; Peykova L; Fischer A
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):296-304. PubMed ID: 26847096
[TBL] [Abstract][Full Text] [Related]
64. Targeting CD20 in the treatment of interstitial lung diseases related to connective tissue diseases: A systematic review.
Bellan M; Patrucco F; Barone-Adesi F; Gavelli F; Castello LM; Nerviani A; Andreoli L; Cavagna L; Pirisi M; Sainaghi PP
Autoimmun Rev; 2020 Feb; 19(2):102453. PubMed ID: 31838163
[TBL] [Abstract][Full Text] [Related]
65. [Treatment of lung fibrosis in systemic rheumatic diseases (new treatment)].
Buschulte K; Hoffmann-Vold AM; Dobrota RD; Höger P; Krause A; Kreuter M
Z Rheumatol; 2021 Oct; 80(8):743-754. PubMed ID: 34505934
[TBL] [Abstract][Full Text] [Related]
66. [Interstitial lung disease in connective tissue disorders].
Mouthon L; Berezné A; Brauner M; Valeyre D; Guillevin L
Rev Pneumol Clin; 2005 Jun; 61(3):211-9. PubMed ID: 16142195
[TBL] [Abstract][Full Text] [Related]
67. Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases.
Hagaman JT; Panos RJ; McCormack FX; Thakar CV; Wikenheiser-Brokamp KA; Shipley RT; Kinder BW
Chest; 2011 Feb; 139(2):353-360. PubMed ID: 20688927
[TBL] [Abstract][Full Text] [Related]
68. Management of systemic sclerosis: the first five years.
Roofeh D; Khanna D
Curr Opin Rheumatol; 2020 May; 32(3):228-237. PubMed ID: 32205570
[TBL] [Abstract][Full Text] [Related]
69. Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease.
Hamada T; Samukawa T; Kumamoto T; Hatanaka K; Tsukuya G; Yamamoto M; Machida K; Watanabe M; Mizuno K; Higashimoto I; Inoue Y; Inoue H
BMC Pulm Med; 2015 Sep; 15():110. PubMed ID: 26424433
[TBL] [Abstract][Full Text] [Related]
70. Lung Cancer development and mortality in interstitial lung disease with and without connective tissue diseases: a five-year Nationwide population-based study.
Choi WI; Lee DY; Choi HG; Lee CW
Respir Res; 2019 Jun; 20(1):117. PubMed ID: 31182103
[TBL] [Abstract][Full Text] [Related]
71. Management of systemic sclerosis-associated interstitial lung disease.
Roofeh D; Jaafar S; Vummidi D; Khanna D
Curr Opin Rheumatol; 2019 May; 31(3):241-249. PubMed ID: 30870216
[TBL] [Abstract][Full Text] [Related]
72. Systemic Sclerosis Associated Interstitial Lung Disease: A Comprehensive Overview.
Mackintosh JA; Stainer A; Barnett JL; Renzoni EA
Semin Respir Crit Care Med; 2019 Apr; 40(2):208-226. PubMed ID: 31137061
[TBL] [Abstract][Full Text] [Related]
73. Characteristics of Connective Tissue Diseases Associated Interstitial Lung Diseases - A Single Centre Study in Sri Lanka.
Jayasinghe P; Wickramasinghe N; Krishnakumar P; Sadikeen A; Fernando A
Ceylon Med J; 2021 Mar; 66(1):38-43. PubMed ID: 34984895
[TBL] [Abstract][Full Text] [Related]
74. Interstitial lung disease evaluation: detecting connective tissue disease.
Fischer A; Lee JS; Cottin V
Respiration; 2015; 90(3):177-84. PubMed ID: 26343272
[TBL] [Abstract][Full Text] [Related]
75. Developing disease activity and response criteria in connective tissue disease-related interstitial lung disease.
Saketkoo LA; Matteson EL; Brown KK; Seibold JR; Strand V;
J Rheumatol; 2011 Jul; 38(7):1514-8. PubMed ID: 21724725
[TBL] [Abstract][Full Text] [Related]
76. [Lung transplantation for connective tissue disease-associated interstitial lung disease recipient].
Zhang J; Wu B; Zhou M; Liu D; Fan L; Wei D; Yang H; Chen JY
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Oct; 40(10):744-748. PubMed ID: 29050128
[No Abstract] [Full Text] [Related]
77. Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease.
Oldham JM; Lee C; Valenzi E; Witt LJ; Adegunsoye A; Hsu S; Chen L; Montner S; Chung JH; Noth I; Vij R; Strek ME
Respir Med; 2016 Dec; 121():117-122. PubMed ID: 27888985
[TBL] [Abstract][Full Text] [Related]
78. Pathologic Separation of Chronic Hypersensitivity Pneumonitis From Fibrotic Connective Tissue Disease-associated Interstitial Lung Disease.
Churg A; Wright JL; Ryerson CJ
Am J Surg Pathol; 2017 Oct; 41(10):1403-1409. PubMed ID: 28614213
[TBL] [Abstract][Full Text] [Related]
79. Safety and efficacy of rituximab in connective tissue disease-associated interstitial lung disease: A systematic review and meta-analysis.
Xing NS; Fan GZ; Yan F; Liu YP; Zhang R
Int Immunopharmacol; 2021 Jun; 95():107524. PubMed ID: 33721757
[TBL] [Abstract][Full Text] [Related]
80. Azathioprine for Connective Tissue Disease-Associated Interstitial Lung Disease.
Boerner EB; Cuyas M; Theegarten D; Ohshimo S; Costabel U; Bonella F
Respiration; 2020; 99(8):628-636. PubMed ID: 32663826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
